Apalutamide treatment of locally advanced prostate cancer Case report

Main Article Content

Maria Palasik

Abstract

Prostate cancer is most commonly diagnosed cancer in men. The choice of treatment method depends on many factors: the patient’s age, other patient’s diseases, psychophysical status and expected survival time. Hormonotherapy plays very important role in patients with no possible radical treatment. New therapies apply in patients with castration-resistant metastatic prostate cancer. First registered drug in patients with biochemical progression without metastases is apalutamide.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Palasik M. Apalutamide treatment of locally advanced prostate cancer. OncoReview [Internet]. 2023Mar.31 [cited 2024May30];13(1(49):31-2. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/2792
Section
SUPPORTIVE CARE IN ONCOLOGY

References

1. Krajowy Rejestr Nowotworów 2021 r.
2. Smith MR, Saad F, Chowdhury S et al. Apalutamide and Overall Survival in Prostate Cancer. Eur Urol. 2021; 79(1): 150-8.